GlassScriptPhysician profile
Ayman Mahdy
NPI 1023248911
$11,561.50
in general payments reported to CMS, 2019-2025
18 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $1,243 · 2021: $1,538 · 2022: $676 · 2023: $2,677 · 2024: $3,054 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Food and Beverage: $3,145 · Travel and Lodging: $44.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Food and Beverage | $3,144.79 |
| Travel and Lodging | $44.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,969.79 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,948.49 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $1,781.78 | 2019-2020 | |
| Boston Scientific Corporation | $901.25 | 2019-2025 | Axonics, Lithovue, 8/10 Dilator/Sheath Set |
| Astellas Pharma US INC | $361.74 | 2019-2021 | |
| Procept Biorobotics Corporation | $298.05 | 2025 | |
| Teleflex LLC | $272.69 | 2022-2023 | Urolift |
| Sumitomo Pharma America, INC. | $187.92 | 2023-2025 | Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $178.78 | 2023-2024 | Bard Urinary Drainage Bag |
| Abbvie INC. | $175.29 | 2023-2024 | |
| Coloplast Corp | $152.46 | 2020 | |
| Dornier Medtech America, INC | $123.88 | 2022 | |
| Janssen Biotech, INC. | $113.40 | 2021 | |
| Rochester Medical Corporation | $35.52 | 2019-2022 | |
| Blue Earth Diagnostics | $24.39 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $21.82 | 2019 | |
| Endo Pharmaceuticals INC. | $14.25 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Mahdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.